![Keith Blundy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keith Blundy
Director/Miembro de la Junta en Nodus Oncology Ltd. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Scott Doak | M | 62 |
Nodus Oncology Ltd.
![]() Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
Ian Waddell | M | 61 |
Nodus Oncology Ltd.
![]() Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
Nicola Broughton | M | - |
Nodus Oncology Ltd.
![]() Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 años |
Clare Wareing | M | 61 |
Nodus Oncology Ltd.
![]() Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
Bert Klebl | M | - |
Nodus Oncology Ltd.
![]() Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
Julia Mary Brown | F | 58 |
Nodus Oncology Ltd.
![]() Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 años |
Manuelle Debunne | M | - |
Nodus Oncology Ltd.
![]() Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 años |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
Reino Unido | 7 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Keith Blundy
- Red Personal